A rat immobilized for 24 hours will develop ulcerations in the glandular area of the stomach."'3 Although these ulcers or erosions have been attributed to stress, the mechanism that causes them is unknown.! Both vagotomy and anticholinergic drugs reduce the incidence of these ulcers, suggesting the role of acid in their production.2"'3 Studies to date, however, have failed to show consistently increased acid secretion in restrained animals."' Moreno and Brodie have suggested that restraint ulcers resemble those produced by high doses of histamine. Since the mucosa of the rat's stomach contains much histamine,8 and has a high histamineforming capacity (HFC),9 it seemed of interest to ascertain whether histamine is a mediator of restraint ulcers.
number or grade the severity of the ulcerations; only the presence or absence of ulcers was noted.
Histamine-forming capacity was measured by a revision of Schayer's method.2 Instead of crystallizing the histamine as dibenzenesulfonyl histamine, the hydrochloric acid extract of the butanol which contains the histamine was counted directly. The full procedure is as follows: The full thickness glandular area of the stomach was removed from the rat, and at once placed in a test tube and immersed in a dry ice ethanol bath for quick freezing. The tissues were then stored at -20' C. until used. The frozen glandular portion of the stomach was thawed and a 10 per cent tissue homogenate in phosphate buffer made. This was divided into three 0.4 ml. portions.
One portion was evaporated to dryness in a weighed container to be utilized for determination of the dry weight of tissue. Another portion was boiled for five minutes for use as a tissue blank. The blank and the remaining aliquot was then incubated with 2.0 ml. of phosphate buffer, pH 7.2, (containing 0.2 per cent glucose), and 7.5 gamma of C1' L-histidine (S.ACT. 21.6/ c/mm Nuclear Chicago Corp.) under nitrogen for three hours at 370 C. After incubation, 1 ml. of a solution containing 16.5 mg. L-histidine monohydrochloride and 0.5 mg. histamine dihydrochloride as carrier was added. Two milliliters of a 0.6N perchloric acid was then added, the solution was mixed and allowed to stand for 20 minutes. The solution was then transferred to a test tube, and centrifuged for 10 minutes. Two milliliters of the supernatant was then transferred into a vial containing 1.5 gm. NaCI, 10 ml. of watersaturated butanol, and 0.5 ml. 10 N NaOH. The vial was vigorously shaken for 15 minutes and then centrifuged for five minutes. A 0.7 ml. aliquot of the clear top butanol layer, which contains the histamine, was then transferred to another vial and washed twice with 2 mil. of a 0.1 N NaOH solution saturated with NaCl. After five minutes of centrifugation the bottom layer was discarded. A 5 ml. aliquot of the remaining butanol layer was then placed in a new vial containing 2 ml. of 0.1 N HCI. The solution was shaken for 15 minutes and then centrifuged for five. The top layer was aspirated and discarded; 0.2 ml. of the bottom was then removed and placed in a vial that had previously been counted containing 15 ml. of a counting solution prepared by dissolving 4 gm. of PPO* in 1,000 ml. of Toluene and 500 ml. of absolute ethyl alcohol, for counting in a liquid scintillation spectrometer (Nuclear Chicago). Spectrofluorometric analysis of the hydrochloric-acid extract confirmed full recovery of the carrier histamine. To ascertain that the observed counts actually represented newly formed C1-histamine by the tissues and not unconverted C'histidine, the histamine-forming capacity of duplicate aliquots of homogenates of two control animals were run, with and without incubation.
In samples without incubation no counts were obtained in the hydrochloric-acid extract. The difference between the count of the sample and tissue blank were expressed in terms of the dry weight of the sample as counts per minute of derived histamine per 0.1 mg. dry weight of tissue.
Gastric secretion was collected for four hours by the method described by Shay, et al.' The gastric juice was measured for volume and total acidity, titrating electrometrically to a pH of 7 with 0.1 N NaOH. Results are expressed in mEq HCl per hour. The following experiments were done:
(1) 31 pyridoxine-deficient rats and 44 control-fed rats underwent restraint. The stomachs of 11 pyridoxine-deficient, and 11 control rats were assayed for HFC.
Pyridoxine Deficiency and Ulcers THAYER, TOFFLER, CHAPO, SPIRO Histologic and histochemical studies consisting of triphosphopyridinenucleotide diaphorase, nonspecific esterase (Holt's method), monoamine oxidase (Glenner method), acid phosphatase, and lactic dehydrogenase were carried out1' on the gastric mucosa of both the normal and pyridoxine-deficient animals.
(2) Gastric secretion was measured in 16 pyridoxine-deficient rats and 24 control rats. In order to make it unnecessary to express gastric secretion in terms of weight, normal rats of weights identical to the pyridoxine-deficient rats were selected; all rats weighed between 275 and 330 gm.
(3) Six pairs of rats, litter mates, were raised on identically weighed pyridoxinedeficient diets for three months; one rat of each pair received a daily oral supplement of 25 mg. of pyridoxine. At the end of the three-month period, both members of each pair were restrained in the usual fashion. (4) Four control rats were given intra-peritoneal injections of deoxypyridoxine, 25 mg. daily for two weeks, while another four animals were given a pyridoxinedeficient diet along with the daily intra-peritoneal injections of 25 mg. of deoxypyridoxine. Three animals were fed a pyridoxine-deficient diet alone for two weeks.
(5) Eight rats were given diphenhydramine hydrochloride intraperitoneally 50 mg. pre kg. twice daily on the day before and the day of restraint.
(6) Six rats were given alpha-methyl-DOPA (alpha-methyl-3,4, dihydroxyphenylalanine, Aldomet) 250 mg. per kg. twice daily for seven days intraperitoneally. At the end of this time they underwent restraint. HFC determinations were carried out on their stomachs. (7) Fonur rats were given intraperitoneal injections of alpha-methyl-histidine 250 mg. per kg. twice daily for seven days before being restrained. HFC determinations were carried out on their stomachs.
(8) Four rats were injected intraperitoneally with semicarbazide 75 mg. per kg. twice daily for seven days and then restrained. HFC determinations were carried out on two of the animals.
RESULTS
In experiment 1 we see that pyridoxine deficiency inhibited the development of restraint ulcers (Table 1 ). This was not an effect of starvation or of secondary vitamin deficiency since animals kept on the same diet but given small supplements of pyridoxine (experiment 3) were as susceptible to the development of restraint ulcers as were the control animals (Table 2 ). In spite of equal caloric intake the pyridoxine-supplemented group weighed 30 ± 20 gm. more than the deficient group. Similar results were reported by Boullin.' Also the incidence of restraint ulcers was reduced in animals that had been fed the pyridoxine-deficient diet for two weeks only, along with the pyridoxine antagonist, deoxypyridoxine (experiment 4). With the exception of two animals that did develop ulcers the HFC of the pyridoxine-deficient group was much lower than that of the controls (Fig. 1) . In experiment 2, gastric hydrochloric acid secretion was markedly diminished in the pyridoxine-deficient rats ( Table 3) .
The anti-histamine diphenhydramine hydrochloride (experiment 5) and the histidine decarboxylase inhibitors, alpha-methyl-DOPA (experiment 6), alpha-methyl histidine (experiment 7), and semicarbazide (experiment 8) all failed to prevent restraint ulcers ( Pyridoxine Deficiency and Ulcers I rIIAY ER, TOFFLER, CHAPO, SP'IRO per 0.1 mg. tissue respectively. These results are similar to those of the control animals ( Fig. 1) .
No structural or histochemical differences in the gastric mucosa were noted between the pyridoxine-deficient rats and their controls. 
DISCUSSION
Histamine is formed from the decarboxylation of histidine, a reaction catalyzed by the enzyme histidine decarboxylase, and its coenzyme pyridoxal-5-phosphate.NM Pyridoxine deficiency decreases histamine-forming capacity in tissues.'7 These experiments suggest that it is the pyridoxine deficiency that reduces histamine formation, and circumstantially that this reduction in histamine-forming capacity is responsible for the observed decrease in the incidence of ulcerations in the stomach. Since two pyridoxine-deficient animals with normal levels of gastric HFC were the ones that developed ulcers, histamine may be one of the mediators of restraint ulceration.
The present finding of a decreased HFC after pyridoxine deficiency is more striking than those of Kahlson, et al, whose experimental animals ate a pyridoxine-deficient diet for only two weeks.' The reduced HFC was not the result of a reduction in histidine decarboxylase, but rather of the pyridoxal-5-phosphate cofactor; when pyridoxal-5-phosphate was added to the homogenate in vitro, normal levels of activity resulted. It must be kept in mind that pyridoxal-5-phosphate is a coenzyme for many other reactions, being required for practically all the reactions involving the non-oxidative degradation and interconversion of free amino acids.l' A block in some other pathway dependent on pyridoxal-5-phosphate might be responsible for the results noted here.
Our technique for HFC determination is a modification of that of Schayer and others"' and for this reason the values of HFC in this report are not necessarily comparable to theirs. Our technique avoids crystallization of the dibenzenesulfonyl histamine and thereby shortens the procedure without apparently decreasing its accuracy.
Selye has shown that prior restraint markedly diminishes an animal's general response to a histamine liberator, 48-80.' Selye suggested that this was the result of protection by endogenous corticoids, but an alternative explanation suggested by the present experiments is that restraint so exhausted the histamine stores that there could be no further response to a histamine liberator.
The failure to prevent restraint ulcers by the use of antihistaminics was not unexpected, since these agents do not reduce the incidence of histamine ulcerations." We did not find a reduction in the incidence of ulcers with alpha-methyl-DOPA, alpha-methyl-histidine, and semicar-bazide, which are inhibitors of histidine decarboxylase ;" however, in vAvo these substances are not very potent histidine decarboxylase inhibitors and did not lead to significant depression of the HFC in the stomach of our rats.
Since histamine will not produce ulcers in the absence of acid,' it is thought that the decrease in acid secretion in these rats protected them against the restraint ulcers. The finding of a decreased gastric acid secretion in the pyridoxine-deficient rats confirms earlier work of Hawk and Hundley.' Histamine is a known gastric acid stimulant and the inhibition of restraint ulcers in the pyridoxine-deficient rats may well be related to the marked suppression of acid production. If the depressed secretion of acid in these stomachs is indeed related to a decrease in endogenous histamine, the stomachs of the pyridoxine-deficient animals should respond to exogenous histamine normally. These results are the subject of a preliminary report;' histamine in a dose of 10 mg/kg. to eight normals and eight pyridoxine-deficient animals gave volumes of 0.143 ± .026 meq H+/hr. and 0.136 ± .024 mEq H+/hr respectively showing that the pyridoxine-deficient stomach can respond normally to histamine. These results and the depression of basal gastric acid secretion in the pyridoxinedeficient rat may be taken as evidence that endogenous histamine is an important gastric secretogogue. Such a reduction in acid would then be a factor in protecting the stomach from the restraint ulcers. SUMMARY Pyridoxine deficiency in the rat definitely decreases the incidence of restraint ulcers and depresses gastric secretion. It is suggested that since pyridoxine deficiency lowers histamine-forming capacity, this reduction in endogenous histamine leads to a decrease in acid production which then protects against restraint ulcers.
